跳至主要内容
临床试验/NCT05468970
NCT05468970招募中不适用

Single-center Real World Prospective Observational Study of Clinical Features, Treatment Patterns, and Survival of Bone and Soft Tissue Tumors

Henan Cancer Hospital1 个研究点 分布在 1 个国家目标入组 6,000 人开始时间: 2022年8月3日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
6,000
试验地点
1
主要终点
Overall survival

研究概览

简要总结

It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.

详细描述

It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor. This study is a single-center, prospective, real-world observational study that plans to enroll all eligible patients. Basic information, treatment methods, and prognostic information of these patients were collected.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
6 Years 至 99 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • All ages, male and female.
  • The pathological diagnosis of BSTS in our hospital was a subtype.
  • Has received at least one hospitalization in this hospital.
  • The target lesions could be evaluated according to the efficacy evaluation criteria of solid tumor (RECIST; Version 1.1) Measure diameter changes.

排除标准

  • No definite pathology.

结局指标

主要结局

Overall survival

时间窗: Up to approximately 120months

Pathologically confirmed events leading to death

6/5000 Progression-free survival

时间窗: Up to approximately 48months

The time from the first use of the treatment to the observation of disease progression

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Wang Jiaqiang

Associate chief physician

Henan Cancer Hospital

研究点 (1)

Loading locations...

相似试验